| 1 | orally | 4,880 |
| 2 | intravenously | 2,264 |
| 3 | subcutaneously | 882 |
| 4 | intramuscularly | 569 |
| 5 | topically | 457 |
| 6 | intraperitoneally | 442 |
| 7 | vaginally | 415 |
| 8 | prophylactically | 244 |
| 9 | parenterally | 231 |
| 10 | intranasally | 183 |
| 11 | percutaneously | 122 |
| 12 | intrathecally | 104 |
| 13 | intragastrically | 94 |
| 14 | sublingually | 92 |
| 15 | rectally | 90 |
| 16 | intravaginally | 68 |
| 17 | enterally | 65 |
| 18 | epidurally | 65 |
| 19 | intradermally | 64 |
| 20 | nasally | 45 |
| 21 | cyclically | 44 |
| 22 | adjunctively | 34 |
| 23 | transdermally | 31 |
| 24 | intravesically | 27 |
| 25 | intra-articularly | 26 |
| 26 | perorally | 26 |
| 27 | intratracheally | 25 |
| 28 | transversely | 21 |
| 29 | transurethrally | 20 |
| 30 | intraarticularly | 16 |
| 31 | intra-arterially | 15 |
| 32 | intracerebroventricularly | 15 |
| 33 | intravitreally | 15 |
| 34 | spinally | 14 |
| 35 | subgingivally | 11 |
| 36 | transcervically | 10 |
| 37 | decocted | 9 |
| 38 | non-occlusally | 9 |
| 39 | subconjunctivally | 9 |
| 40 | submucosally | 9 |
| 41 | discontinuously | 8 |
| 42 | ibond | 8 |
| 43 | mesiodistally | 8 |
| 44 | perineurally | 8 |
| 45 | pre-emptively | 8 |
| 46 | twice/week | 8 |
| 47 | ²²³ra | 8 |
| 48 | intraarterially | 7 |
| 49 | intratumorally | 7 |
| 50 | subdermally | 7 |
| 51 | intra-gastrically | 6 |
| 52 | intracervically | 6 |
| 53 | intracoronarily | 6 |
| 54 | intraventricularly | 6 |
| 55 | buccolingually | 5 |
| 56 | intra-peritoneally | 5 |
| 57 | intra-tracheally | 5 |
| 58 | intracranially | 5 |
| 59 | intraduodenally | 5 |
| 60 | intragastricly | 5 |
| 61 | intramyocardially | 5 |
| 62 | intraportally | 5 |
| 63 | intrarectally | 5 |
| 64 | intraruminally | 5 |
| 65 | intratympanically | 5 |
| 66 | lullabies | 5 |
| 67 | postcoitally | 5 |
| 68 | preseasonally | 5 |
| 69 | subchronically | 5 |
| 70 | transvenously | 5 |
| 71 | xylazine/ketamine | 5 |
| 72 | ecosprin | 4 |
| 73 | endocardially | 4 |
| 74 | endovenously | 4 |
| 75 | extradurally | 4 |
| 76 | intracerebrally | 4 |
| 77 | intracutaneously | 4 |
| 78 | intralesionally | 4 |
| 79 | iohexol-350 | 4 |
| 80 | mifepriston | 4 |
| 81 | neoadjuvantly | 4 |
| 82 | nocturnally | 4 |
| 83 | non-peeled | 4 |
| 84 | precoitally | 4 |
| 85 | predilections | 4 |
| 86 | subacromially | 4 |
| 87 | subendocardially | 4 |
| 88 | transendocardially | 4 |
| 89 | xfdcp | 4 |
| 90 | 3-triol | 3 |
| 91 | 400μg | 3 |
| 92 | 40iu | 3 |
| 93 | 4μg/kg | 3 |
| 94 | 5-days-a-week | 3 |
| 95 | adp21-50 | 3 |
| 96 | bcecf-am | 3 |
| 97 | bronuck | 3 |
| 98 | dermally | 3 |
| 99 | dose/g | 3 |
| 100 | efla943 | 3 |
| 101 | en101 | 3 |
| 102 | enhancer-wl | 3 |
| 103 | i.m.. | 3 |
| 104 | intra-nasally | 3 |
| 105 | intra-rectally | 3 |
| 106 | intracavernously | 3 |
| 107 | intraperitonally | 3 |
| 108 | intraperitonially | 3 |
| 109 | intraumbilically | 3 |
| 110 | intravascularly | 3 |
| 111 | odps | 3 |
| 112 | periarticularly | 3 |
| 113 | periurethrally | 3 |
| 114 | permaquick | 3 |
| 115 | persicatm | 3 |
| 116 | prepurified | 3 |
| 117 | rasis | 3 |
| 118 | s.c.. | 3 |
| 119 | stereotaxically | 3 |
| 120 | teat-sealant | 3 |
| 121 | transversally | 3 |
| 122 | tribromoethanol | 3 |
| 123 | vcp205 | 3 |
| 124 | .chm | 2 |
| 125 | 20/01/03 | 2 |
| 126 | 30/10/2002 | 2 |
| 127 | 3ap4 | 2 |
| 128 | 5000iu | 2 |
| 129 | 6mgkg-¹ | 2 |
| 130 | 732.2 | 2 |
| 131 | albumin-ifnα2b | 2 |
| 132 | alpha-phenyl | 2 |
| 133 | bucco-lingually | 2 |
| 134 | distolingually | 2 |
| 135 | extraamniotically | 2 |
| 136 | ftivazid | 2 |
| 137 | goshuyu-to | 2 |
| 138 | hallucinating | 2 |
| 139 | hylak | 2 |
| 140 | i.c.v. | 2 |
| 141 | intra-camerally | 2 |
| 142 | intra-muscularly | 2 |
| 143 | intraductally | 2 |
| 144 | intramammarily | 2 |
| 145 | intrasplenically | 2 |
| 146 | intrastriatally | 2 |
| 147 | lactinex | 2 |
| 148 | mcc-crm197 | 2 |
| 149 | mesio-distally | 2 |
| 150 | met-gh | 2 |
| 151 | metronomically | 2 |
| 152 | muons | 2 |
| 153 | noncontingently | 2 |
| 154 | nonstatins | 2 |
| 155 | oromucosally | 2 |
| 156 | p-sro | 2 |
| 157 | peri-incisionally | 2 |
| 158 | perianally | 2 |
| 159 | periareolarly | 2 |
| 160 | periprostatically | 2 |
| 161 | poskm | 2 |
| 162 | post-consent | 2 |
| 163 | postplacentally | 2 |
| 164 | provase | 2 |
| 165 | r-568 | 2 |
| 166 | rs/d | 2 |
| 167 | self-incentives | 2 |
| 168 | shallowly | 2 |
| 169 | sokei-kakketsu-to | 2 |
| 170 | standard-potency | 2 |
| 171 | transbucally | 2 |
| 172 | transtracheally | 2 |
| 173 | ultracortene-h | 2 |
| 174 | ‘tianwang | 2 |
| 175 | 0.3-10μg | 1 |
| 176 | 01/06/09 | 1 |
| 177 | 1,800-mg/day | 1 |
| 178 | 1-norm | 1 |
| 179 | 1.74g/kg | 1 |
| 180 | 10mls | 1 |
| 181 | 15.11.01 | 1 |
| 182 | 400/100mg | 1 |
| 183 | 533/133mg | 1 |
| 184 | 8.75mg | 1 |
| 185 | 80/40/80 | 1 |
| 186 | =1mg | 1 |
| 187 | =2mg | 1 |
| 188 | adenosine2a | 1 |
| 189 | ambiphrya | 1 |
| 190 | anodynes | 1 |
| 191 | anticholinergic-oxybutynin | 1 |
| 192 | before/after/during | 1 |
| 193 | birth.there | 1 |
| 194 | bivs | 1 |
| 195 | c592g | 1 |
| 196 | carbamate-irs | 1 |
| 197 | cauteously | 1 |
| 198 | ceftriaxone/ornidazole | 1 |
| 199 | celiacly | 1 |
| 200 | cell-puramatrix™ | 1 |
| 201 | cementfree | 1 |
| 202 | chromium-nicotinate | 1 |
| 203 | clinic-initiated | 1 |
| 204 | continuouly | 1 |
| 205 | control-feed | 1 |
| 206 | curcunine | 1 |
| 207 | dacthal | 1 |
| 208 | daily-1 | 1 |
| 209 | dhea-enanthate | 1 |
| 210 | diol/g | 1 |
| 211 | donor-organs | 1 |
| 212 | dosages.when | 1 |
| 213 | dply/phtd | 1 |
| 214 | du-6859a | 1 |
| 215 | e2:0.13mg/kg/d | 1 |
| 216 | eighty-item | 1 |
| 217 | emgfp | 1 |
| 218 | epicrestally | 1 |
| 219 | every-3-months | 1 |
| 220 | femur-were | 1 |
| 221 | fluouroracil | 1 |
| 222 | fst-ll | 1 |
| 223 | g-gr/d | 1 |
| 224 | gastrically | 1 |
| 225 | hcd-enriched | 1 |
| 226 | health-visitor | 1 |
| 227 | hmm+iptc | 1 |
| 228 | hydroxyprednisone | 1 |
| 229 | i.pl. | 1 |
| 230 | immaturely | 1 |
| 231 | industrywide | 1 |
| 232 | inhalatively | 1 |
| 233 | inteviewer | 1 |
| 234 | intra-amniotically | 1 |
| 235 | intra-crop | 1 |
| 236 | intra-gluteally | 1 |
| 237 | intra-tumourally | 1 |
| 238 | intra-umbilically | 1 |
| 239 | intra-urethrically | 1 |
| 240 | intraartricular | 1 |
| 241 | intrabronchially | 1 |
| 242 | intradermallly | 1 |
| 243 | intrafascicularly | 1 |
| 244 | intrahippocampally | 1 |
| 245 | intramenstrually | 1 |
| 246 | intraperitonelly | 1 |
| 247 | intrapulmonarily | 1 |
| 248 | intraputamenally | 1 |
| 249 | intrastromally | 1 |
| 250 | intratendinously | 1 |
| 251 | intratumourally | 1 |
| 252 | intravasally | 1 |
| 253 | intravitreously | 1 |
| 254 | lauriad® | 1 |
| 255 | leuprolide/bicalutamide | 1 |
| 256 | levothyroxine/day | 1 |
| 257 | lidocanine | 1 |
| 258 | living-training | 1 |
| 259 | manually/bodily | 1 |
| 260 | mate-outcome | 1 |
| 261 | methenaminehippurate | 1 |
| 262 | methyprednisolone | 1 |
| 263 | midazolam/placebo | 1 |
| 264 | moxaverine-hydrochloride | 1 |
| 265 | nasoenterically | 1 |
| 266 | neuraxially | 1 |
| 267 | nijututo | 1 |
| 268 | okt3-based | 1 |
| 269 | once-/twice-/thrice-daily | 1 |
| 270 | oxytotics | 1 |
| 271 | parentyerally | 1 |
| 272 | pavulon | 1 |
| 273 | per-orally | 1 |
| 274 | perianal-intrarectally | 1 |
| 275 | pericapsularly | 1 |
| 276 | peridurally | 1 |
| 277 | perivenously | 1 |
| 278 | peroraly | 1 |
| 279 | post-orally | 1 |
| 280 | post-symptomatically | 1 |
| 281 | power3-cifn-α | 1 |
| 282 | presymptomatically | 1 |
| 283 | qids-cr | 1 |
| 284 | quasi-statically | 1 |
| 285 | rechemotherapy | 1 |
| 286 | remifentanil/hour | 1 |
| 287 | results.pegloticase | 1 |
| 288 | rf-tricom | 1 |
| 289 | s.c./week | 1 |
| 290 | saha/kg | 1 |
| 291 | seisinrensiin | 1 |
| 292 | single-crowns | 1 |
| 293 | single/repeated | 1 |
| 294 | stepwisely | 1 |
| 295 | sub-group-matched | 1 |
| 296 | subcutaneosly | 1 |
| 297 | sulfadiazine-trimethroprim | 1 |
| 298 | sulfanegen | 1 |
| 299 | suprachoroidally | 1 |
| 300 | taniia:60mg/kg/d | 1 |
| 301 | teat-sealants | 1 |
| 302 | teeth/s | 1 |
| 303 | transorbitally | 1 |
| 304 | trimetoprim-sulphametoxazole | 1 |
| 305 | twice-once | 1 |
| 306 | were/was | 1 |
| 307 | wormer | 1 |
| 308 | xylasine | 1 |
| 309 | xylazine-guaifenesin | 1 |
| 310 | zeolite/cow | 1 |
| 311 | δvolume | 1 |
| 312 | μ-hole | 1 |
| 1 | .chm | 2 |
| 2 | 0.3-10μg | 1 |
| 3 | 01/06/09 | 1 |
| 4 | 1,800-mg/day | 1 |
| 5 | 1-norm | 1 |
| 6 | 1.74g/kg | 1 |
| 7 | 10mls | 1 |
| 8 | 15.11.01 | 1 |
| 9 | 20/01/03 | 2 |
| 10 | 3-triol | 3 |
| 11 | 30/10/2002 | 2 |
| 12 | 3ap4 | 2 |
| 13 | 400/100mg | 1 |
| 14 | 400μg | 3 |
| 15 | 40iu | 3 |
| 16 | 4μg/kg | 3 |
| 17 | 5-days-a-week | 3 |
| 18 | 5000iu | 2 |
| 19 | 533/133mg | 1 |
| 20 | 6mgkg-¹ | 2 |
| 21 | 732.2 | 2 |
| 22 | 8.75mg | 1 |
| 23 | 80/40/80 | 1 |
| 24 | =1mg | 1 |
| 25 | =2mg | 1 |
| 26 | adenosine2a | 1 |
| 27 | adjunctively | 34 |
| 28 | adp21-50 | 3 |
| 29 | albumin-ifnα2b | 2 |
| 30 | alpha-phenyl | 2 |
| 31 | ambiphrya | 1 |
| 32 | anodynes | 1 |
| 33 | anticholinergic-oxybutynin | 1 |
| 34 | bcecf-am | 3 |
| 35 | before/after/during | 1 |
| 36 | birth.there | 1 |
| 37 | bivs | 1 |
| 38 | bronuck | 3 |
| 39 | bucco-lingually | 2 |
| 40 | buccolingually | 5 |
| 41 | c592g | 1 |
| 42 | carbamate-irs | 1 |
| 43 | cauteously | 1 |
| 44 | ceftriaxone/ornidazole | 1 |
| 45 | celiacly | 1 |
| 46 | cell-puramatrix™ | 1 |
| 47 | cementfree | 1 |
| 48 | chromium-nicotinate | 1 |
| 49 | clinic-initiated | 1 |
| 50 | continuouly | 1 |
| 51 | control-feed | 1 |
| 52 | curcunine | 1 |
| 53 | cyclically | 44 |
| 54 | dacthal | 1 |
| 55 | daily-1 | 1 |
| 56 | decocted | 9 |
| 57 | dermally | 3 |
| 58 | dhea-enanthate | 1 |
| 59 | diol/g | 1 |
| 60 | discontinuously | 8 |
| 61 | distolingually | 2 |
| 62 | donor-organs | 1 |
| 63 | dosages.when | 1 |
| 64 | dose/g | 3 |
| 65 | dply/phtd | 1 |
| 66 | du-6859a | 1 |
| 67 | e2:0.13mg/kg/d | 1 |
| 68 | ecosprin | 4 |
| 69 | efla943 | 3 |
| 70 | eighty-item | 1 |
| 71 | emgfp | 1 |
| 72 | en101 | 3 |
| 73 | endocardially | 4 |
| 74 | endovenously | 4 |
| 75 | enhancer-wl | 3 |
| 76 | enterally | 65 |
| 77 | epicrestally | 1 |
| 78 | epidurally | 65 |
| 79 | every-3-months | 1 |
| 80 | extraamniotically | 2 |
| 81 | extradurally | 4 |
| 82 | femur-were | 1 |
| 83 | fluouroracil | 1 |
| 84 | fst-ll | 1 |
| 85 | ftivazid | 2 |
| 86 | g-gr/d | 1 |
| 87 | gastrically | 1 |
| 88 | goshuyu-to | 2 |
| 89 | hallucinating | 2 |
| 90 | hcd-enriched | 1 |
| 91 | health-visitor | 1 |
| 92 | hmm+iptc | 1 |
| 93 | hydroxyprednisone | 1 |
| 94 | hylak | 2 |
| 95 | i.c.v. | 2 |
| 96 | i.m.. | 3 |
| 97 | i.pl. | 1 |
| 98 | ibond | 8 |
| 99 | immaturely | 1 |
| 100 | industrywide | 1 |
| 101 | inhalatively | 1 |
| 102 | inteviewer | 1 |
| 103 | intra-amniotically | 1 |
| 104 | intra-arterially | 15 |
| 105 | intra-articularly | 26 |
| 106 | intra-camerally | 2 |
| 107 | intra-crop | 1 |
| 108 | intra-gastrically | 6 |
| 109 | intra-gluteally | 1 |
| 110 | intra-muscularly | 2 |
| 111 | intra-nasally | 3 |
| 112 | intra-peritoneally | 5 |
| 113 | intra-rectally | 3 |
| 114 | intra-tracheally | 5 |
| 115 | intra-tumourally | 1 |
| 116 | intra-umbilically | 1 |
| 117 | intra-urethrically | 1 |
| 118 | intraarterially | 7 |
| 119 | intraarticularly | 16 |
| 120 | intraartricular | 1 |
| 121 | intrabronchially | 1 |
| 122 | intracavernously | 3 |
| 123 | intracerebrally | 4 |
| 124 | intracerebroventricularly | 15 |
| 125 | intracervically | 6 |
| 126 | intracoronarily | 6 |
| 127 | intracranially | 5 |
| 128 | intracutaneously | 4 |
| 129 | intradermallly | 1 |
| 130 | intradermally | 64 |
| 131 | intraductally | 2 |
| 132 | intraduodenally | 5 |
| 133 | intrafascicularly | 1 |
| 134 | intragastrically | 94 |
| 135 | intragastricly | 5 |
| 136 | intrahippocampally | 1 |
| 137 | intralesionally | 4 |
| 138 | intramammarily | 2 |
| 139 | intramenstrually | 1 |
| 140 | intramuscularly | 569 |
| 141 | intramyocardially | 5 |
| 142 | intranasally | 183 |
| 143 | intraperitonally | 3 |
| 144 | intraperitoneally | 442 |
| 145 | intraperitonelly | 1 |
| 146 | intraperitonially | 3 |
| 147 | intraportally | 5 |
| 148 | intrapulmonarily | 1 |
| 149 | intraputamenally | 1 |
| 150 | intrarectally | 5 |
| 151 | intraruminally | 5 |
| 152 | intrasplenically | 2 |
| 153 | intrastriatally | 2 |
| 154 | intrastromally | 1 |
| 155 | intratendinously | 1 |
| 156 | intrathecally | 104 |
| 157 | intratracheally | 25 |
| 158 | intratumorally | 7 |
| 159 | intratumourally | 1 |
| 160 | intratympanically | 5 |
| 161 | intraumbilically | 3 |
| 162 | intravaginally | 68 |
| 163 | intravasally | 1 |
| 164 | intravascularly | 3 |
| 165 | intravenously | 2,264 |
| 166 | intraventricularly | 6 |
| 167 | intravesically | 27 |
| 168 | intravitreally | 15 |
| 169 | intravitreously | 1 |
| 170 | iohexol-350 | 4 |
| 171 | lactinex | 2 |
| 172 | lauriad® | 1 |
| 173 | leuprolide/bicalutamide | 1 |
| 174 | levothyroxine/day | 1 |
| 175 | lidocanine | 1 |
| 176 | living-training | 1 |
| 177 | lullabies | 5 |
| 178 | manually/bodily | 1 |
| 179 | mate-outcome | 1 |
| 180 | mcc-crm197 | 2 |
| 181 | mesio-distally | 2 |
| 182 | mesiodistally | 8 |
| 183 | met-gh | 2 |
| 184 | methenaminehippurate | 1 |
| 185 | methyprednisolone | 1 |
| 186 | metronomically | 2 |
| 187 | midazolam/placebo | 1 |
| 188 | mifepriston | 4 |
| 189 | moxaverine-hydrochloride | 1 |
| 190 | muons | 2 |
| 191 | nasally | 45 |
| 192 | nasoenterically | 1 |
| 193 | neoadjuvantly | 4 |
| 194 | neuraxially | 1 |
| 195 | nijututo | 1 |
| 196 | nocturnally | 4 |
| 197 | non-occlusally | 9 |
| 198 | non-peeled | 4 |
| 199 | noncontingently | 2 |
| 200 | nonstatins | 2 |
| 201 | odps | 3 |
| 202 | okt3-based | 1 |
| 203 | once-/twice-/thrice-daily | 1 |
| 204 | orally | 4,880 |
| 205 | oromucosally | 2 |
| 206 | oxytotics | 1 |
| 207 | p-sro | 2 |
| 208 | parenterally | 231 |
| 209 | parentyerally | 1 |
| 210 | pavulon | 1 |
| 211 | per-orally | 1 |
| 212 | percutaneously | 122 |
| 213 | peri-incisionally | 2 |
| 214 | perianal-intrarectally | 1 |
| 215 | perianally | 2 |
| 216 | periareolarly | 2 |
| 217 | periarticularly | 3 |
| 218 | pericapsularly | 1 |
| 219 | peridurally | 1 |
| 220 | perineurally | 8 |
| 221 | periprostatically | 2 |
| 222 | periurethrally | 3 |
| 223 | perivenously | 1 |
| 224 | permaquick | 3 |
| 225 | perorally | 26 |
| 226 | peroraly | 1 |
| 227 | persicatm | 3 |
| 228 | poskm | 2 |
| 229 | post-consent | 2 |
| 230 | post-orally | 1 |
| 231 | post-symptomatically | 1 |
| 232 | postcoitally | 5 |
| 233 | postplacentally | 2 |
| 234 | power3-cifn-α | 1 |
| 235 | pre-emptively | 8 |
| 236 | precoitally | 4 |
| 237 | predilections | 4 |
| 238 | prepurified | 3 |
| 239 | preseasonally | 5 |
| 240 | presymptomatically | 1 |
| 241 | prophylactically | 244 |
| 242 | provase | 2 |
| 243 | qids-cr | 1 |
| 244 | quasi-statically | 1 |
| 245 | r-568 | 2 |
| 246 | rasis | 3 |
| 247 | rechemotherapy | 1 |
| 248 | rectally | 90 |
| 249 | remifentanil/hour | 1 |
| 250 | results.pegloticase | 1 |
| 251 | rf-tricom | 1 |
| 252 | rs/d | 2 |
| 253 | s.c.. | 3 |
| 254 | s.c./week | 1 |
| 255 | saha/kg | 1 |
| 256 | seisinrensiin | 1 |
| 257 | self-incentives | 2 |
| 258 | shallowly | 2 |
| 259 | single-crowns | 1 |
| 260 | single/repeated | 1 |
| 261 | sokei-kakketsu-to | 2 |
| 262 | spinally | 14 |
| 263 | standard-potency | 2 |
| 264 | stepwisely | 1 |
| 265 | stereotaxically | 3 |
| 266 | sub-group-matched | 1 |
| 267 | subacromially | 4 |
| 268 | subchronically | 5 |
| 269 | subconjunctivally | 9 |
| 270 | subcutaneosly | 1 |
| 271 | subcutaneously | 882 |
| 272 | subdermally | 7 |
| 273 | subendocardially | 4 |
| 274 | subgingivally | 11 |
| 275 | sublingually | 92 |
| 276 | submucosally | 9 |
| 277 | sulfadiazine-trimethroprim | 1 |
| 278 | sulfanegen | 1 |
| 279 | suprachoroidally | 1 |
| 280 | taniia:60mg/kg/d | 1 |
| 281 | teat-sealant | 3 |
| 282 | teat-sealants | 1 |
| 283 | teeth/s | 1 |
| 284 | topically | 457 |
| 285 | transbucally | 2 |
| 286 | transcervically | 10 |
| 287 | transdermally | 31 |
| 288 | transendocardially | 4 |
| 289 | transorbitally | 1 |
| 290 | transtracheally | 2 |
| 291 | transurethrally | 20 |
| 292 | transvenously | 5 |
| 293 | transversally | 3 |
| 294 | transversely | 21 |
| 295 | tribromoethanol | 3 |
| 296 | trimetoprim-sulphametoxazole | 1 |
| 297 | twice-once | 1 |
| 298 | twice/week | 8 |
| 299 | ultracortene-h | 2 |
| 300 | vaginally | 415 |
| 301 | vcp205 | 3 |
| 302 | were/was | 1 |
| 303 | wormer | 1 |
| 304 | xfdcp | 4 |
| 305 | xylasine | 1 |
| 306 | xylazine-guaifenesin | 1 |
| 307 | xylazine/ketamine | 5 |
| 308 | zeolite/cow | 1 |
| 309 | ²²³ra | 8 |
| 310 | δvolume | 1 |
| 311 | μ-hole | 1 |
| 312 | ‘tianwang | 2 |
| 1 | s.c.. | 3 |
| 2 | i.m.. | 3 |
| 3 | i.pl. | 1 |
| 4 | i.c.v. | 2 |
| 5 | adp21-50 | 3 |
| 6 | iohexol-350 | 4 |
| 7 | 80/40/80 | 1 |
| 8 | daily-1 | 1 |
| 9 | 15.11.01 | 1 |
| 10 | en101 | 3 |
| 11 | 732.2 | 2 |
| 12 | 30/10/2002 | 2 |
| 13 | 20/01/03 | 2 |
| 14 | efla943 | 3 |
| 15 | 3ap4 | 2 |
| 16 | vcp205 | 3 |
| 17 | mcc-crm197 | 2 |
| 18 | r-568 | 2 |
| 19 | 01/06/09 | 1 |
| 20 | adenosine2a | 1 |
| 21 | du-6859a | 1 |
| 22 | ²²³ra | 8 |
| 23 | ambiphrya | 1 |
| 24 | albumin-ifnα2b | 2 |
| 25 | hmm+iptc | 1 |
| 26 | taniia:60mg/kg/d | 1 |
| 27 | e2:0.13mg/kg/d | 1 |
| 28 | g-gr/d | 1 |
| 29 | rs/d | 2 |
| 30 | control-feed | 1 |
| 31 | hcd-enriched | 1 |
| 32 | sub-group-matched | 1 |
| 33 | prepurified | 3 |
| 34 | non-peeled | 4 |
| 35 | okt3-based | 1 |
| 36 | single/repeated | 1 |
| 37 | clinic-initiated | 1 |
| 38 | decocted | 9 |
| 39 | ftivazid | 2 |
| 40 | ibond | 8 |
| 41 | dply/phtd | 1 |
| 42 | twice-once | 1 |
| 43 | leuprolide/bicalutamide | 1 |
| 44 | moxaverine-hydrochloride | 1 |
| 45 | industrywide | 1 |
| 46 | cementfree | 1 |
| 47 | μ-hole | 1 |
| 48 | ceftriaxone/ornidazole | 1 |
| 49 | trimetoprim-sulphametoxazole | 1 |
| 50 | mate-outcome | 1 |
| 51 | δvolume | 1 |
| 52 | xylazine/ketamine | 5 |
| 53 | lidocanine | 1 |
| 54 | curcunine | 1 |
| 55 | xylasine | 1 |
| 56 | methyprednisolone | 1 |
| 57 | hydroxyprednisone | 1 |
| 58 | birth.there | 1 |
| 59 | femur-were | 1 |
| 60 | results.pegloticase | 1 |
| 61 | provase | 2 |
| 62 | dhea-enanthate | 1 |
| 63 | chromium-nicotinate | 1 |
| 64 | methenaminehippurate | 1 |
| 65 | dose/g | 3 |
| 66 | diol/g | 1 |
| 67 | c592g | 1 |
| 68 | saha/kg | 1 |
| 69 | 1.74g/kg | 1 |
| 70 | 4μg/kg | 3 |
| 71 | 400/100mg | 1 |
| 72 | =1mg | 1 |
| 73 | =2mg | 1 |
| 74 | 533/133mg | 1 |
| 75 | 8.75mg | 1 |
| 76 | ‘tianwang | 2 |
| 77 | living-training | 1 |
| 78 | before/after/during | 1 |
| 79 | hallucinating | 2 |
| 80 | 400μg | 3 |
| 81 | 0.3-10μg | 1 |
| 82 | ultracortene-h | 2 |
| 83 | met-gh | 2 |
| 84 | hylak | 2 |
| 85 | permaquick | 3 |
| 86 | bronuck | 3 |
| 87 | 5-days-a-week | 3 |
| 88 | s.c./week | 1 |
| 89 | twice/week | 8 |
| 90 | dacthal | 1 |
| 91 | fluouroracil | 1 |
| 92 | fst-ll | 1 |
| 93 | 3-triol | 3 |
| 94 | tribromoethanol | 3 |
| 95 | enhancer-wl | 3 |
| 96 | alpha-phenyl | 2 |
| 97 | bcecf-am | 3 |
| 98 | eighty-item | 1 |
| 99 | .chm | 2 |
| 100 | sulfadiazine-trimethroprim | 1 |
| 101 | poskm | 2 |
| 102 | rf-tricom | 1 |
| 103 | 1-norm | 1 |
| 104 | persicatm | 3 |
| 105 | sulfanegen | 1 |
| 106 | dosages.when | 1 |
| 107 | seisinrensiin | 1 |
| 108 | anticholinergic-oxybutynin | 1 |
| 109 | ecosprin | 4 |
| 110 | xylazine-guaifenesin | 1 |
| 111 | pavulon | 1 |
| 112 | mifepriston | 4 |
| 113 | midazolam/placebo | 1 |
| 114 | p-sro | 2 |
| 115 | sokei-kakketsu-to | 2 |
| 116 | goshuyu-to | 2 |
| 117 | nijututo | 1 |
| 118 | xfdcp | 4 |
| 119 | emgfp | 1 |
| 120 | intra-crop | 1 |
| 121 | intraartricular | 1 |
| 122 | qids-cr | 1 |
| 123 | wormer | 1 |
| 124 | inteviewer | 1 |
| 125 | health-visitor | 1 |
| 126 | remifentanil/hour | 1 |
| 127 | teeth/s | 1 |
| 128 | were/was | 1 |
| 129 | oxytotics | 1 |
| 130 | lullabies | 5 |
| 131 | anodynes | 1 |
| 132 | self-incentives | 2 |
| 133 | every-3-months | 1 |
| 134 | rasis | 3 |
| 135 | 10mls | 1 |
| 136 | donor-organs | 1 |
| 137 | nonstatins | 2 |
| 138 | predilections | 4 |
| 139 | muons | 2 |
| 140 | single-crowns | 1 |
| 141 | odps | 3 |
| 142 | carbamate-irs | 1 |
| 143 | teat-sealants | 1 |
| 144 | bivs | 1 |
| 145 | teat-sealant | 3 |
| 146 | post-consent | 2 |
| 147 | 5000iu | 2 |
| 148 | 40iu | 3 |
| 149 | zeolite/cow | 1 |
| 150 | lactinex | 2 |
| 151 | levothyroxine/day | 1 |
| 152 | 1,800-mg/day | 1 |
| 153 | standard-potency | 2 |
| 154 | peroraly | 1 |
| 155 | celiacly | 1 |
| 156 | intragastricly | 5 |
| 157 | immaturely | 1 |
| 158 | stepwisely | 1 |
| 159 | transversely | 21 |
| 160 | inhalatively | 1 |
| 161 | adjunctively | 34 |
| 162 | pre-emptively | 8 |
| 163 | once-/twice-/thrice-daily | 1 |
| 164 | manually/bodily | 1 |
| 165 | intramammarily | 2 |
| 166 | intrapulmonarily | 1 |
| 167 | intracoronarily | 6 |
| 168 | intrathecally | 104 |
| 169 | cyclically | 44 |
| 170 | intra-umbilically | 1 |
| 171 | intraumbilically | 3 |
| 172 | metronomically | 2 |
| 173 | intratympanically | 5 |
| 174 | intrasplenically | 2 |
| 175 | subchronically | 5 |
| 176 | topically | 457 |
| 177 | nasoenterically | 1 |
| 178 | intra-urethrically | 1 |
| 179 | gastrically | 1 |
| 180 | intra-gastrically | 6 |
| 181 | intragastrically | 94 |
| 182 | intravesically | 27 |
| 183 | post-symptomatically | 1 |
| 184 | presymptomatically | 1 |
| 185 | quasi-statically | 1 |
| 186 | periprostatically | 2 |
| 187 | prophylactically | 244 |
| 188 | intra-amniotically | 1 |
| 189 | extraamniotically | 2 |
| 190 | intracervically | 6 |
| 191 | transcervically | 10 |
| 192 | stereotaxically | 3 |
| 193 | transbucally | 2 |
| 194 | suprachoroidally | 1 |
| 195 | intra-tracheally | 5 |
| 196 | intratracheally | 25 |
| 197 | transtracheally | 2 |
| 198 | intra-peritoneally | 5 |
| 199 | intraperitoneally | 442 |
| 200 | intravitreally | 15 |
| 201 | intra-gluteally | 1 |
| 202 | endocardially | 4 |
| 203 | subendocardially | 4 |
| 204 | transendocardially | 4 |
| 205 | intramyocardially | 5 |
| 206 | intrabronchially | 1 |
| 207 | subacromially | 4 |
| 208 | intracranially | 5 |
| 209 | intraperitonially | 3 |
| 210 | intra-arterially | 15 |
| 211 | intraarterially | 7 |
| 212 | neuraxially | 1 |
| 213 | intrastromally | 1 |
| 214 | dermally | 3 |
| 215 | intradermally | 64 |
| 216 | subdermally | 7 |
| 217 | transdermally | 31 |
| 218 | perianally | 2 |
| 219 | intraduodenally | 5 |
| 220 | intraputamenally | 1 |
| 221 | vaginally | 415 |
| 222 | intravaginally | 68 |
| 223 | intraruminally | 5 |
| 224 | spinally | 14 |
| 225 | intralesionally | 4 |
| 226 | peri-incisionally | 2 |
| 227 | preseasonally | 5 |
| 228 | intraperitonally | 3 |
| 229 | nocturnally | 4 |
| 230 | intrahippocampally | 1 |
| 231 | intracerebrally | 4 |
| 232 | intra-camerally | 2 |
| 233 | enterally | 65 |
| 234 | parenterally | 231 |
| 235 | parentyerally | 1 |
| 236 | periurethrally | 3 |
| 237 | transurethrally | 20 |
| 238 | orally | 4,880 |
| 239 | per-orally | 1 |
| 240 | post-orally | 1 |
| 241 | intratumorally | 7 |
| 242 | perorally | 26 |
| 243 | extradurally | 4 |
| 244 | epidurally | 65 |
| 245 | peridurally | 1 |
| 246 | perineurally | 8 |
| 247 | intra-tumourally | 1 |
| 248 | intratumourally | 1 |
| 249 | nasally | 45 |
| 250 | intra-nasally | 3 |
| 251 | intranasally | 183 |
| 252 | intravasally | 1 |
| 253 | submucosally | 9 |
| 254 | oromucosally | 2 |
| 255 | transversally | 3 |
| 256 | non-occlusally | 9 |
| 257 | intrastriatally | 2 |
| 258 | rectally | 90 |
| 259 | intra-rectally | 3 |
| 260 | intrarectally | 5 |
| 261 | perianal-intrarectally | 1 |
| 262 | intraductally | 2 |
| 263 | transorbitally | 1 |
| 264 | precoitally | 4 |
| 265 | postcoitally | 5 |
| 266 | postplacentally | 2 |
| 267 | intraportally | 5 |
| 268 | epicrestally | 1 |
| 269 | mesio-distally | 2 |
| 270 | mesiodistally | 8 |
| 271 | bucco-lingually | 2 |
| 272 | sublingually | 92 |
| 273 | buccolingually | 5 |
| 274 | distolingually | 2 |
| 275 | intramenstrually | 1 |
| 276 | subgingivally | 11 |
| 277 | subconjunctivally | 9 |
| 278 | intraperitonelly | 1 |
| 279 | intradermallly | 1 |
| 280 | periareolarly | 2 |
| 281 | intrafascicularly | 1 |
| 282 | intraventricularly | 6 |
| 283 | intracerebroventricularly | 15 |
| 284 | intra-articularly | 26 |
| 285 | intraarticularly | 16 |
| 286 | periarticularly | 3 |
| 287 | intravascularly | 3 |
| 288 | intra-muscularly | 2 |
| 289 | intramuscularly | 569 |
| 290 | pericapsularly | 1 |
| 291 | subcutaneosly | 1 |
| 292 | intracutaneously | 4 |
| 293 | subcutaneously | 882 |
| 294 | percutaneously | 122 |
| 295 | intravitreously | 1 |
| 296 | cauteously | 1 |
| 297 | intravenously | 2,264 |
| 298 | perivenously | 1 |
| 299 | endovenously | 4 |
| 300 | transvenously | 5 |
| 301 | intratendinously | 1 |
| 302 | intracavernously | 3 |
| 303 | discontinuously | 8 |
| 304 | neoadjuvantly | 4 |
| 305 | noncontingently | 2 |
| 306 | continuouly | 1 |
| 307 | shallowly | 2 |
| 308 | rechemotherapy | 1 |
| 309 | cell-puramatrix™ | 1 |
| 310 | lauriad® | 1 |
| 311 | power3-cifn-α | 1 |
| 312 | 6mgkg-¹ | 2 |